Unlocking the potential of bacteria: Nature’s greatest innovators
Our Story
The ErebaGen platform builds on 25 years of world-leading research from Professor Greg Challis’ lab, offering cost-effective, safer, and sustainable alternatives to traditional chemical processes. Our technology harnesses specialised metabolism to discover and develop biocatalysts, small molecules and bacteria to tackle challenging synthetic chemistry problems. Using our proprietary technologies we can enable rapid activation and precise editing of bacterial pathways for industrial use, opening immense opportunities to exploit hidden biosynthetic tools.
At ErebaGen, we are pioneering the next frontier of innovation by harnessing the immense potential of microbes. These tiny organisms hold the key to groundbreaking discoveries that can revolutionise human health, agriculture, and biotechnology.
Our platform consists of three key components designed to unlock specialised metabolism for scalable, industrial applications: Scout, Forge and Mine.
A word from our CSO
Microbial chemistry is amazing. Through 25 years of research into microbial specialised metabolism, we have seen how Nature has evolved to solve its own chemical challenges, and how these solutions can translate into industrial applications. We can utilise the bacteria, biocatalysts and small molecules that have evolved over millions of years to transform industrial processes and improve lives. It is fascinating to see the incredible machinery microbes have developed to build complex molecules beyond the reach of current synthetic methods.
Our mission is to harness the largely untapped potential of microbes to create solutions to some of the world’s most pressing challenges. At ErebaGen, innovation is at the heart of what we do and I am excited for us to continue to apply Nature’s toolkit to solve real world problems.